The potential of palbociclib for the treatment of FLT3-ITD+ AML
Can BCR inhibitors be used to treat all CLL patients or only a subset?
From the microenvironment to the CLL patient
Challenges in cancer care: why we need to coordinate a worldwide effort against cancer
Individualizing patient care in CML and MPNs